• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Tackling medical AI bias will improve health equity for all

Blog
Article
Medical Economics JournalMedical Economics March 2024
Volume 101
Issue 3

AI bias is a threat to patient health: ©wladimir1804 - stock.adobe.com

AI bias is a threat to patient health: ©wladimir1804 - stock.adobe.com

Systemic racial biases persistently shape the health care experiences of Black, Latinx and Indigenous populations. These biases are especially pronounced for women of color, influencing everything from diagnosis and family planning to treatment recommendations. In fact, Centers for Disease Control and Prevention data show that Black women are two to three times more likely to die from pregnancy-related complications than non-Hispanic White women, with most of the maternal deaths being preventable and harming the population regardless of income and education level.

These alarming trends are present at the earliest stages of life, with Black infants being four times as likely as non-Hispanic White infants to die from complications of low birth weight. When addressing health care disparities, we must acknowledge the role that representation plays in the space. Whether it is decreasing mortality among Black newborns, improving cardiovascular health or simply building trust to further adhere to medical guidelines and create a safe place for patients of color, there is power in representation and what it can do for historically overlooked communities.

Oversight is necessary

When it comes to the implementation of new artificial intelligence (AI) tools in health care oversight is necessary, and representation must be required before the products reach patients. This must be done to ensure that the biases entrenched in our current systems aren’t inadvertently bolstered or perpetuated by such technologies. This past year, a study from the Stanford University School of Medicine revealed that AI chatbots were producing racist health information with little to no oversight, which can further perpetuate disparities and worsen health outcomes for individuals of color.

Therefore, at every stage, from funding to reaching the lives of patients, new health care AI tools must be overseen for racial and gender biases.

Trusting AI tools

Within the medical space, we are asking patients from diverse communities to trust AI tools with their lives and health outcomes. These are the AI tools that are often built and backed by groups that did little to consider communities of color as patients in the creation of their products. To create equitable health care processes using AI, we must place ourselves in the shoes of the communities that are often overlooked and underrepresented to understand how to build this trust and to further build tools with diverse communities in mind.

Ultimately, we cannot expect AI to become an equitable health care tool without addressing the deeply ingrained racial and gender biases that continually cost lives and damage health outcomes.

The overall health care venture capital market is vast, with $14 billion being raised in the first half of 2023, potentially bringing it near to 2021’s record pace. When looking for solutions that target these biases in the medical space, we must question fund managers who are sourcing and funding these AI and tech solutions. It is necessary to understand whether fund managers are prioritizing race and gender disparities in their decisions and how capital is being moved to solutions that are improving patient outcomes. We must consider how fund managers are making their decisions and what kind of questions they are asking in their due diligence process before they allocate millions of dollars into the next big AI solution.

By addressing biases, we have an opportunity to make an impact and create economic value by driving patient outcomes.

Building an equal future

Leaders must question a product before it reaches their patients and ask how their products are benefiting the communities they aim to engage with. We have already seen the positive effects of having representative health care providers. The next step to implementing equitable health care tools is to prioritize the diverse experiences of communities that shape the input for all AI tools, advance the technological tools and improve patient outcomes. We must create solutions patients can trust, and AI tools are no different.

A future of truly equal health care involves eradicating the biases that plague our current health system and creating tools that improve patients’ lives. Technology has the opportunity to expand access, reduce costs and refine therapeutics in numerous ways that can address new markets and diverse consumers –– but we must use it with equity in mind.

Furthermore, an inclusive and optimal health care industry is the cornerstone of an equitable future.

Daryn Dodson is the managing director of Illumen Capital.

Related Videos
Kyle Zebley headshot
Kyle Zebley headshot
Kyle Zebley headshot
Michael J. Barry, MD
Hadi Chaudhry, President and CEO, CareCloud
Claire Ernst, JD, gives expert advice
Arien Malec